Jeena Sikho Lifecare shares soar 8% on receiving NABH accreditation for its Bhopal hospital

At around 10:51 AM, the stock was trading at ₹705.55 per equity share, marking a 1.91% increase.

The scrip has gained more than 14% in the past week and nearly 5% over the month. On a year-to-date basis, it has advanced 5%.

While the share hit a 52-week high of ₹849.50 apiece on September 23, 2025, it touched a year’s low of ₹400.25 on June 19, 2025.

“The receipt of the NABH accreditation signifies adherence to nationally recognised standards for quality healthcare delivery, patient safety, and operational excellence,” according to a regulatory filing.

The development has occurred in the ordinary course of business and does not constitute business expansion, capacity enhancement, or acquisition, the filing added.

As of March 31, 2026, before the recent accreditation, the firm had 50 NABH-accredited hospitals and clinics, with three in the pipeline, according to its investor presentation.

Bulk deal

Aside from receiving the accreditation, 8,04,137 shares of Jeena Sikho Lifecare changed hands on June 3.

Microcurves Trading Pvt Ltd sold 8,04,137 shares for ₹661.37 apiece, and bought the same number of shares for ₹661.13 per unit, as per data on the NSE.

Jeena Sikho Lifecare Q4 results

The company reported a 78.1% year-on-year (YoY) jump in its consolidated net profit to ₹45.13 crore in the fourth quarter of the 2025-26 financial year (Q4 FY26), compared with ₹25.34 crore in the year-ago period.

Its revenue from operations stood at ₹215.55 crore during the quarter under review, reflecting a 54.79% YoY increase from ₹139.25 crore in the March quarter of the 2024-25 fiscal year (Q4 FY25).

Its board of directors had also recommended a final dividend of ₹4.50 per equity share with a face value of ₹2 each for the financial year 2025-26, subject to shareholder approval at the ensuing Annual General Meeting (AGM).

Jeena Sikho Lifecare has a total market capitalisation of ₹8,778.12 crore as of June 4, 2026, according to data on the NSE.